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Abstract 
 
Both migraine and vertigo are common in the general population with lifetime prevalences of 
about 16% for migraine and 7% for vertigo. Therefore, a concurrence of the two conditions 
can be expected in about 1.1% percent of the general population by chance alone. However, 
recent epidemiological evidence suggests that the actual comorbidity is higher, namely 3.2 %. 
This can be explained by the fact that several dizziness and vertigo syndromes occur more 
frequently in  migraineurs than in controls including benign paroxysmal positional vertigo, 
Meniere’s disease, motion sickness, cerebellar disorders and anxiety syndromes which may 
present with dizziness. In addition, there is increasing recognition of a syndrome called 
vestibular migraine (VM), which is vertigo directly caused by migraine. VM affects more 
than 1% of the general population, about 10% of patients in dizziness clinics and at least 9% 
of patients in migraine clinics. 
Clinically, VM presents with attacks of spontaneous or positional vertigo lasting 
seconds to days. Migrainous accompaniments such as headache, phonophobia, photophobia or 
auras are common but not mandatory. Cochlear symptoms may be associated but are mostly 
mild and non-progressive. During acute attacks one may find central spontaneous or 
positional nystagmus and, less commonly, unilateral vestibular hypofunction. In the 
symptom-free interval, vestibular testing adds little to the diagnosis as findings are mostly 
minor and non-specific. In the absence of controlled studies, treatment of VM is adopted from 
the migraine sphere comprising avoidance of triggers, stress management as well as 
pharmacotherapy for acute attacks and prophylaxis. 
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Introduction 
Recognition of an association between migraine and vertigo dates back almost 150 years 
when the English physician Edward Living noted that six out of 60 patients with migraine had 
spontaneous attacks of vertigo, as documented in his monograph On megrim: a contribution 
to the study of nerve storms [37] That about 10% of migraineurs suffer from vertigo caused by 
migraine has been confirmed quite recently [41] but the interrelations of migraine and vertigo 
are more complex. First of all, vertigo and migraine may coexist in the same individual by 
chance alone, as both are common conditions in the general population. Moreover, several 
vertigo syndromes have been shown to be epidemiologically associated with migraine: benign 
paroxysmal positional vertigo, Meniere’s disease, motion sickness, cerebellar disorders and 
several psychiatric syndromes which may present with dizziness. Finally, there is vestibular 
migraine (VM), which is recurrent vertigo as a symptom of migraine. 
 
Epidemiology of migraine 
The epidemiology of migraine has been investigated by population-based studies in various 
countries on the basis of the International Classification of Headache Disorders [28]. Lifetime 
prevalences have been largely consistent across industrialized countries ranging from 13% 
[11,36] to 16% [21,49]. Women were affected two to three times more often than men. The one 
year prevalence of migraine has been estimated at 11% according to a metaanalysis 
comprising numerous studies from around the world [55]. 
  
Epidemiology of vertigo 
Several studies have tried to assess the epidemiology of dizziness, which is a broad term, that 
includes vertigo and non-vestibular dizziness. Dizziness was found to be one of the most 
common complaints in medicine, affecting approximately 20% to 30% of the general 
population [32,63,25]. The epidemiology of vestibular vertigo was investigated only recently by 
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means of a two stage approach [46]. The first step was a telephone screening of a 
representative general population sample (German National Health Interview Survey, 
n=4,869) for moderate or severe dizziness or vertigo, followed by detailed validated 
neurotologic interviews (n=1003). The lifetime prevalence of vertigo in adults aged 18-79 
was 7%, the one-year prevalence 4.9% and the one-year incidence 1.4%. Interestingly, there 
was a marked female preponderance among individuals with vertigo (one year prevalence 
ratio male to female 1:2.7).  The study also showed that vertigo is recurrent in the vast 
majority of patients (88%). Vertigo has a considerable individual and social impact, causing 
interruption of daily activities in 40% of affected individuals, sick leave in 41% and 
avoidance of leaving the house in 19% according to a recent survey [44]. 
 
Epidemiological association of migraine and vertigo 
An increased comorbidity of migraine and vertigo, which exceeds what random chance would 
predict, was identified in various selected patient groups and later confirmed on the 
population level. Notably there is no single study, that did not confirm such an association. 
Vertigo is two to three times more common in patients with migraine than in headache-free 
controls [33,59] and in patients with tension-type headaches [31]. Vice versa, the prevalence of 
migraine has been shown to be elevated among patients with unclassified or idiopathic vertigo 
[2,34,54]. Similarly, migraine prevalence was 1.6 times higher in 200 consective patients from a 
dizziness clinic than in matched orthopedic controls [41].  
The lifetime prevalences of migraine (16%) and vertigo (7%) lead to an expected comorbidity 
of the two conditions in 1.1% of the general population. The actual comorbidity, however, as 
identified by the German National Health Survey, was 3.2% [42]. A more recent population-
based study showed that individuals with migraine were much more likely to have vertigo and 
vertigo with accompanying headache (OR 3.8 and 8 respectively) than non-migraineurs after 
adjustment for age and sex [45]. 
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Specific vertigo syndromes associated with migraine 
Benign paroxysmal positional vertigo 
Benign paroxysmal positional vertigo (BPPV) is the most common vestibular disorder both in 
unselected patients [7] and in migraineurs [41] presenting to a dizziness clinic. Migraine is 
three times more common in patients with idiopathic BPPV than in patients with BPPV 
secondary to trauma or surgical procedures [29]. Moreover, migraine was two times more 
common in patients with idiopathic BPPV than in age and sex-matched controls [35]. Genetic 
factors and vascular damage to the labyrinth have been discussed as pathogenetic mechanisms 
linking the two conditions [29]. 
 
Menière’s disease 
An increased prevalence of migraine in patients with Menière’s disease (MD) is well 
documented [51,50].  Migraine was twice as high in a group of 78 patients with unilateral or 
bilateral MD (based on the American Academy of Otolaryngology criteria), than in an age- 
and sex-matched control group (56% vs. 25%, p<0.001) [51]. Migraine leads to a greater 
susceptibility of developing MD, as suggested by a study in which MD patients had an earlier 
onset of symptoms and a greater frequency of bilateral hearing loss when they also had 
migraine [15]. 
  
Motion sickness 
Motion sickness is more prevalent in patients with migraine (30% to 70%)  than in headache-
free controls or tension headaches (20% to 40%)[19,31,33,38].  The association is more 
pronounced in children [6] and in migraine with aura [33]  Migraineurs are also prone to 
“visual vertigo” induced by optokinetic stimuli [33,19], which can be conceptualized as a 
decreased threshold for visual-vestibular interaction.   
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Cerebellar disorders 
Cerebellar dysfunction is linked in various ways to migraine [60] but does not normally 
present with “true” vertigo. However, both patients with familial hemiplegic migraine and 
episodic ataxia type 2 may have symptoms of basilar-type migraine including headaches and 
vertigo attacks [24] on the background of slowly progressive cerebellar dysfunction. The 
genetic basis of these disorders are mutations in the CACNA1A gene coding for the 1A 
subunit of a neuronal Ca2+ channel, which is heavily expressed in the cerebellum [17]. 
Cerebellar signs are usually not present in the common types of migraine, but some 
investigators found subclinical hypermetria and other subtle cerebellar signs in patients with 
migraine with, or without aura [53,27].   
 
Psychiatric syndromes 
Dizziness, sometimes perceived as spinning vertigo, is the second most common symptom of 
panic attacks after palpitations [39] and can be a symptom of major depression as well. There 
are bidirectional associations of migraine with both major depression and panic disorder, with 
migraine being a risk factor for first-onset major depression and panic disorder and vice 
versa.[ 10, 12]. 
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Vestibular migraine 
Diagnostic criteria 
Vestibular migraine (synonyms: migrainous vertigo, migraine-associated dizziness, benign 
recurrent vertigo) designates vertigo attacks which are directly caused by migraine. The 
current International Classification of Headache Disorders (ICHD) of the International 
Headache Society does not include vertigo as a migrainous symptom in adults, except in the 
framework of basilar-type migraine (Internat. Classif). For a diagnosis of basilar-type 
migraine, the ICHD requires at least two posterior circulation manifestations lasting between 
5 and 60 minutes, followed by a migraine headache.  Less than 10% of patients with VM 
fulfill these criteria [14,30,18,41] meaning that most adult patients with VM cannot be classified 
with the current criteria. 
Like migraine itself VM is diagnosed on the basis of clinical information as there are 
no specific biological markers. A preliminary classification, using operational clinical criteria 
modeled on the ICHD, proposed two separate diagnostic categories: definite VM and the 
more sensitive but less specific, probable VM [41] (Table 1).   
 
Epidemiology and demographic features of vestibular migraine 
According to these diagnostic criteria, the frequency of definite VM was 7% in a group of 200 
consecutive dizziness clinic patients, and 9% in a group of 200 migraine patients [41].  In a 
population-based study  (n=4869 adults) with screening interviews followed by expert 
telephone interviews (German National Health Survey), the lifetime prevalence of definite 
VM was estimated at 0.98% (95% CI 0.7 – 1.37) [42]. Interestingly, this is considerably less 
than the 3.2% from the same sample who had both migraine and vertigo, partly because 
probable VM was not included and partly because patients with migraine may suffer from 
other vestibular disorders (see above). This emphasizes the necessity of a thorough 
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neurotological evaluation of all patients with migraine and vertigo before making a diagnosis 
of VM. 
VM may occur at any age [16,14,30] with a reported female to male ratio between 1.5 
and 5 to 1 [14,30,18,41]. Familial occurrence is not uncommon, probably based on an autosomal 
dominant pattern of inheritance with decreased penetrance in men [47]. In most patients, 
migraine headaches begin earlier in life than VM [18,41].  Some patients are headache-free for 
years before VM manifests itself [18]. Benign paroxysmal vertigo of childhood is probably an 
early manifestation of VM and affects about 2.8 % of unselected children between the ages of 
6 and 12 years [1]. 
 
Clinical features 
The clinical characteristics of VM have been elucidated by several large case series from 
specialized dizziness clinics [14,16,18,26,30,31,41]. Patients with VM present with spontaneous or 
positional vertigo. Some experience a sequence of spontaneous vertigo transforming into 
positional vertigo later in the attack [40,56]. Altogether, 40-70% of patients have positional 
vertigo (but not benign paroxysmal positional vertigo) in the course of the disease [31,26,56]. 
Head motion intolerance, íe imbalance, illusory motion and nausea aggravated or provoked by 
head movements, is a frequent additional symptom [14,30]. Visual vertigo, which is vertigo 
provoked by moving visual scenes [traffic, cinema] can be another prominent feature of VM 
[14,61].  Nausea and imbalance are frequent but unspecific accompaniments of acute VM.  
Both duration and frequency of attacks can vary between patients and in individual 
patients over time. The duration of vertigo ranges from seconds (about 10%) and minutes 
(30%) to hours (30%) and several days (30%) [16,30,31,18,58]  For some patients, it may take 
weeks to fully recover from an attack. The attacks may occur days, months or even years 
apart in an irregular fashion. Overall, between 10% and 30% of patients have vertigo with the 
typical duration of a migraine aura, i.e. 5 to 60 minutes [18,41].  VM often misses not only the 
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duration criterion for an aura as defined by the IHS, but also the temporal relationship to 
migraine headaches: vertigo can precede headache as would be typical for an aura, may begin 
with headache or appear late in the headache phase. Many patients experience both attacks 
with and without headache and in some, vertigo and headache never occur together [16,41,30]. 
Photophobia, phonophobia, osmophobia and visual or other auras are common 
accompaniments of VM. These phenomena are of diagnostic importance, since they may 
represent the only apparent link between vertigo and migraine. Hearing loss and tinnitus are 
not prominent symptoms of VM but have been reported in individual patients with VM 
[14,30,31,48]. Hearing loss is usually mild and transient, without progression in the course of the 
disorder which discriminates VM from Meniere’s disease [30]. 
Precipitants of attacks may serve as diagnostic clues: menstruation, deficient or 
irregular sleep, excessive stress, relief from stress (weekends, beginning of a holiday), 
specific foods such as matured cheese, red wine and glutamate and finally sensory stimuli 
such as bright or scintillating lights, intense smells or noise. The triggers are highly individual 
and each one applies only for a few percent of the migraine population. 
Psychiatric comorbidity, particularly with anxiety disorders, reaches 65% in VM as 
compared to only 22% in BPPV [20]. In an individual patient, both vestibular and psychiatric 
mechanisms may contribute to the dizziness [22]. These factors need to be weighed carefully 
to direct treatment appropriately. 
 
Findings on examination 
The general neurologic, vestibular and otologic examination is usually normal in the 
symptom-free period [16]. About 10-20% of VM patients have unilateral hypoexcitability to 
caloric stimulation [16]. Neuro-ophthalmological evaluation may reveal mild central 
oculomotor deficits in the absence of other brainstem or cerebellar signs [18]. During the acute 
phase of VM patients often have imbalance and central vestibular findings such as 
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spontaneous downbeating, upbeating or pure torsional nystagmus and/or persistent positional 
nystagmus [56,57]. Some have a transient unilateral peripheral hypofunction with spontaneous 
horizontal nystagmus and an abnormal head thrust test [57]. The pathophysiology of VM is 
unknown. Various hypotheses have been proposed but, so far, none has had any impact on the 
management of these patients [23]. 
  
Treatment 
When attacks of VM attacks are severe and frequent, acute or prophylactic treatment is 
warranted. However, apart from one small and inconclusive study on the use of zolmitriptan 
for acute VM [43] current treatment recommendations are based on expert opinion rather than 
randomized placebo-controlled trials. A few case reports suggest that drugs used for migraine 
prophylaxis may be effective. These  include propranolol [26] metoprolol [18], tricyclic 
antidepressants [52], pizotifen [52,61], topiramate [13] and flunarizine [18]. Lamotrigine [9] and 
the carbonic anhydrase-inhibitors acetazolamide [4] and dichlorphenamid [3] which are not 
ordinarily used for migraine prophylaxis, have also been tried successfully, but these studies 
were not randomized or controlled.   
Treatment of acute VM with acute migraine medication can be attempted with triptans 
[43] and vestibular suppressants such as promethazine, dimenhydrinate, and meclizine [5]. A 
retrospective study found that the effect of triptans on vertigo correlated with its effect on 
headache [8].  Non-pharmaceutical approaches may be more efficacious than drugs in 
individual patients. A thorough explanation of the migrainous origin of the attacks may 
relieve unnecessary fears.Avoidance of identified triggers, stress management and vestibular 
rehabilitation [62] can be helpful.  
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Table 1.  Diagnostic criteria for vestibular migraine [41] 
 Definite vestibular migraine 
A. Episodic vestibular symptoms of at least moderate severity 
B. Current or previous history of migraine according to the 2004 criteria of the International 
Headache Society  
C. One of the following migrainous symptoms during  2 attacks of vertigo: 
 migrainous headache, photophobia, phonophobia, visual or other auras 
D. Other causes ruled out by appropriate investigations 
 Comment:  
Vestibular symptoms are rotational vertigo or another illusory self or object motion. They 
may be spontaneous or positional. Vestibular symptoms are “moderate” if they interfere 
with but do not prohibit daily activities and “severe” if patients cannot continue daily 
activities. 
 Probable vestibular migraine 
A. Episodic vestibular symptoms of at least moderate severity 
B. 
 
One of the following: 
a) Current or previous history of migraine according to the 2004 criteria of the IHS  
b) Migrainous symptoms during vestibular symptoms 
c) Migraine-precipitants of vertigo in more than 50% of attacks: food triggers, sleep 
irregularities, hormonal change 
d) Response to migraine medications in more than 50% of attacks 
C. Other causes ruled out by appropriate investigations 
 
